Pages that link to "Q34359090"
Jump to navigation
Jump to search
The following pages link to Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes (Q34359090):
Displaying 50 items.
- Medical issues and emergencies in the dermatology office (Q33174988) (← links)
- Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry. (Q33422957) (← links)
- Effects of cytochrome p450 inhibitors on itraconazole and fluconazole induced cytotoxicity in hepatocytes (Q33601260) (← links)
- Drug interactions with itraconazole, fluconazole, and terbinafine and their management (Q33699931) (← links)
- Effects of the antifungal agents on oxidative drug metabolism: clinical relevance (Q33858325) (← links)
- Drug interactions with cisapride: clinical implications (Q33991291) (← links)
- Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers (Q34347427) (← links)
- Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations (Q34738805) (← links)
- Adverse drug reactions to systemic antifungals. Prevention and management (Q35453449) (← links)
- Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects (Q35825729) (← links)
- Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide (Q35827146) (← links)
- Antifungal activity of Lactobacillus against Microsporum canis, Microsporum gypseum and Epidermophyton floccosum (Q35976889) (← links)
- Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine (Q36053651) (← links)
- The xenobiotic inhibitor profile of cytochrome P4502C8. (Q36055384) (← links)
- Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies (Q36072448) (← links)
- Drug interactions: Part I (Q36138026) (← links)
- Onychomycosis. Going for cure (Q36479370) (← links)
- New treatments for vulvovaginal candidiasis (Q36625081) (← links)
- Sparse drug concentration data analysis using a population approach: a valuable tool in clinical pharmacology (Q36831644) (← links)
- High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain (Q36982824) (← links)
- Inhibition and induction of human cytochrome P450 enzymes: current status (Q37212794) (← links)
- The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis (Q37489316) (← links)
- Interactions between antifungal and antiretroviral agents (Q37719545) (← links)
- Management of drug and food interactions with azole antifungal agents in transplant recipients (Q37775009) (← links)
- Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro (Q37780212) (← links)
- Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics. (Q37904672) (← links)
- Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models (Q38791118) (← links)
- Evaluation of the effect of fluconazole on the pharmacokinetics of cyclosporin A in healthy dogs after a single dose and at steady-state (Q38825266) (← links)
- P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier. (Q39558031) (← links)
- Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting. (Q39686509) (← links)
- Antifungal agents: an overview. Part II. (Q40449449) (← links)
- Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. (Q40463624) (← links)
- Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors (Q40529215) (← links)
- Pharmacokinetic drug interactions with antimicrobial agents (Q40720380) (← links)
- Clinically significant drug interactions with cyclosporin. An update (Q41201529) (← links)
- Pediatric dermatology: advances in therapy (Q41417472) (← links)
- The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations (Q41478142) (← links)
- Application of Human Liver Microsomes in Metabolism-Based Drug-Drug Interactions: In Vitro-in Vivo Correlations and the Abbott Laboratories Experience (Q41619424) (← links)
- In vitro approaches to predicting drug interactions in vivo. (Q41692688) (← links)
- Systemic antifungal agents. Drug interactions of clinical significance (Q41725883) (← links)
- Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes (Q42132550) (← links)
- Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man (Q43224354) (← links)
- Methadone and fluconazole: respiratory depression by drug interaction (Q43886115) (← links)
- Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers (Q43947373) (← links)
- Itraconazole- and fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study (Q44015814) (← links)
- Semi-micro column HPLC of triazolam in rat plasma and brain microdialysate and its application to drug interaction study with itraconazole (Q44251499) (← links)
- A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation (Q44973658) (← links)
- Rhabdomyolysis in a patient receiving atorvastatin and fluconazole (Q45206650) (← links)
- A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection (Q45754321) (← links)
- Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs. (Q46559888) (← links)